Clinical Trial Update: Liraglutide 3 mg for Knee Osteoarthritis [Phase 4]

View source ↗

Summary

Phase 4 trial update for liraglutide 3 mg in knee osteoarthritis and obesity has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Osteoarthritis

Drugs mentioned

• liraglutide 3 mg (liraglutide)

Snippet

Sponsor: Henrik Gudbergsen | Conditions: Osteoarthritis, Obesity | Phase 4 | Status: COMPLETED